nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—PGR—polycystic ovary syndrome	0.426	0.517	CbGaD
Etonogestrel—SHBG—polycystic ovary syndrome	0.398	0.483	CbGaD
Etonogestrel—PGR—corpus luteum—polycystic ovary syndrome	0.0207	0.241	CbGeAlD
Etonogestrel—PGR—ovarian follicle—polycystic ovary syndrome	0.0162	0.188	CbGeAlD
Etonogestrel—ESR1—ovarian follicle—polycystic ovary syndrome	0.0127	0.147	CbGeAlD
Etonogestrel—CYP3A4—urine—polycystic ovary syndrome	0.00296	0.0344	CbGeAlD
Etonogestrel—SHBG—endometrium—polycystic ovary syndrome	0.00178	0.0207	CbGeAlD
Etonogestrel—ESR1—embryo—polycystic ovary syndrome	0.00172	0.0199	CbGeAlD
Etonogestrel—SHBG—uterus—polycystic ovary syndrome	0.00164	0.0191	CbGeAlD
Etonogestrel—SHBG—pituitary gland—polycystic ovary syndrome	0.00161	0.0187	CbGeAlD
Etonogestrel—SHBG—adipose tissue—polycystic ovary syndrome	0.00161	0.0186	CbGeAlD
Etonogestrel—PGR—endometrium—polycystic ovary syndrome	0.00161	0.0186	CbGeAlD
Etonogestrel—Toothache—Metformin—polycystic ovary syndrome	0.00158	0.072	CcSEcCtD
Etonogestrel—PGR—uterus—polycystic ovary syndrome	0.00148	0.0172	CbGeAlD
Etonogestrel—PGR—pituitary gland—polycystic ovary syndrome	0.00145	0.0169	CbGeAlD
Etonogestrel—PGR—adipose tissue—polycystic ovary syndrome	0.00145	0.0168	CbGeAlD
Etonogestrel—SHBG—adrenal gland—polycystic ovary syndrome	0.00144	0.0167	CbGeAlD
Etonogestrel—SHBG—female gonad—polycystic ovary syndrome	0.00134	0.0156	CbGeAlD
Etonogestrel—SHBG—vagina—polycystic ovary syndrome	0.00133	0.0155	CbGeAlD
Etonogestrel—PGR—adrenal gland—polycystic ovary syndrome	0.0013	0.0151	CbGeAlD
Etonogestrel—ESR1—endometrium—polycystic ovary syndrome	0.00126	0.0146	CbGeAlD
Etonogestrel—SHBG—endocrine gland—polycystic ovary syndrome	0.00125	0.0145	CbGeAlD
Etonogestrel—PGR—female gonad—polycystic ovary syndrome	0.00121	0.0141	CbGeAlD
Etonogestrel—PGR—vagina—polycystic ovary syndrome	0.0012	0.014	CbGeAlD
Etonogestrel—ESR1—uterus—polycystic ovary syndrome	0.00116	0.0134	CbGeAlD
Etonogestrel—ESR1—pituitary gland—polycystic ovary syndrome	0.00114	0.0132	CbGeAlD
Etonogestrel—ESR1—adipose tissue—polycystic ovary syndrome	0.00113	0.0131	CbGeAlD
Etonogestrel—PGR—endocrine gland—polycystic ovary syndrome	0.00113	0.0131	CbGeAlD
Etonogestrel—Contusion—Metformin—polycystic ovary syndrome	0.0011	0.0502	CcSEcCtD
Etonogestrel—ESR1—adrenal gland—polycystic ovary syndrome	0.00101	0.0118	CbGeAlD
Etonogestrel—ESR1—female gonad—polycystic ovary syndrome	0.000946	0.011	CbGeAlD
Etonogestrel—ESR1—vagina—polycystic ovary syndrome	0.000941	0.0109	CbGeAlD
Etonogestrel—ESR1—endocrine gland—polycystic ovary syndrome	0.00088	0.0102	CbGeAlD
Etonogestrel—Levonorgestrel—SRD5A1—polycystic ovary syndrome	0.000816	0.1	CrCbGaD
Etonogestrel—Pain in extremity—Metformin—polycystic ovary syndrome	0.000696	0.0318	CcSEcCtD
Etonogestrel—Migraine—Metformin—polycystic ovary syndrome	0.000685	0.0313	CcSEcCtD
Etonogestrel—Breast disorder—Metformin—polycystic ovary syndrome	0.000629	0.0287	CcSEcCtD
Etonogestrel—Cramp muscle—Metformin—polycystic ovary syndrome	0.000627	0.0286	CcSEcCtD
Etonogestrel—Abdominal distension—Metformin—polycystic ovary syndrome	0.000606	0.0277	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000559	0.0256	CcSEcCtD
Etonogestrel—Infestation NOS—Metformin—polycystic ovary syndrome	0.000536	0.0245	CcSEcCtD
Etonogestrel—Infestation—Metformin—polycystic ovary syndrome	0.000536	0.0245	CcSEcCtD
Etonogestrel—Norelgestromin—PGR—polycystic ovary syndrome	0.000536	0.0658	CrCbGaD
Etonogestrel—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000526	0.024	CcSEcCtD
Etonogestrel—Desogestrel—PGR—polycystic ovary syndrome	0.000516	0.0634	CrCbGaD
Etonogestrel—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000491	0.0057	CbGeAlD
Etonogestrel—Rhinitis—Metformin—polycystic ovary syndrome	0.000483	0.0221	CcSEcCtD
Etonogestrel—Norgestimate—PGR—polycystic ovary syndrome	0.000482	0.0593	CrCbGaD
Etonogestrel—Desogestrel—SHBG—polycystic ovary syndrome	0.000482	0.0592	CrCbGaD
Etonogestrel—Nandrolone phenpropionate—AR—polycystic ovary syndrome	0.00048	0.059	CrCbGaD
Etonogestrel—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000479	0.0219	CcSEcCtD
Etonogestrel—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000473	0.0216	CcSEcCtD
Etonogestrel—Eye disorder—Metformin—polycystic ovary syndrome	0.00045	0.0206	CcSEcCtD
Etonogestrel—Angiopathy—Metformin—polycystic ovary syndrome	0.000437	0.02	CcSEcCtD
Etonogestrel—Immune system disorder—Metformin—polycystic ovary syndrome	0.000435	0.0199	CcSEcCtD
Etonogestrel—Malnutrition—Metformin—polycystic ovary syndrome	0.000419	0.0192	CcSEcCtD
Etonogestrel—Erythema—Metformin—polycystic ovary syndrome	0.000419	0.0192	CcSEcCtD
Etonogestrel—Flatulence—Metformin—polycystic ovary syndrome	0.000413	0.0189	CcSEcCtD
Etonogestrel—Muscle spasms—Metformin—polycystic ovary syndrome	0.000403	0.0184	CcSEcCtD
Etonogestrel—Nandrolone phenpropionate—CYP19A1—polycystic ovary syndrome	0.000402	0.0494	CrCbGaD
Etonogestrel—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000389	0.0178	CcSEcCtD
Etonogestrel—Malaise—Metformin—polycystic ovary syndrome	0.000378	0.0173	CcSEcCtD
Etonogestrel—Nandrolone decanoate—AR—polycystic ovary syndrome	0.000364	0.0447	CrCbGaD
Etonogestrel—Hypertension—Metformin—polycystic ovary syndrome	0.000362	0.0165	CcSEcCtD
Etonogestrel—Myalgia—Metformin—polycystic ovary syndrome	0.000357	0.0163	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000354	0.0162	CcSEcCtD
Etonogestrel—Discomfort—Metformin—polycystic ovary syndrome	0.000353	0.0161	CcSEcCtD
Etonogestrel—Oedema—Metformin—polycystic ovary syndrome	0.000342	0.0156	CcSEcCtD
Etonogestrel—Infection—Metformin—polycystic ovary syndrome	0.00034	0.0155	CcSEcCtD
Etonogestrel—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000336	0.0153	CcSEcCtD
Etonogestrel—Skin disorder—Metformin—polycystic ovary syndrome	0.000332	0.0152	CcSEcCtD
Etonogestrel—Anorexia—Metformin—polycystic ovary syndrome	0.000326	0.0149	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000312	0.0142	CcSEcCtD
Etonogestrel—Paraesthesia—Metformin—polycystic ovary syndrome	0.000307	0.014	CcSEcCtD
Etonogestrel—Nandrolone decanoate—CYP19A1—polycystic ovary syndrome	0.000305	0.0374	CrCbGaD
Etonogestrel—Somnolence—Metformin—polycystic ovary syndrome	0.000304	0.0139	CcSEcCtD
Etonogestrel—Dyspepsia—Metformin—polycystic ovary syndrome	0.000301	0.0138	CcSEcCtD
Etonogestrel—Decreased appetite—Metformin—polycystic ovary syndrome	0.000297	0.0136	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000295	0.0135	CcSEcCtD
Etonogestrel—Levonorgestrel—PGR—polycystic ovary syndrome	0.000295	0.0363	CrCbGaD
Etonogestrel—Fatigue—Metformin—polycystic ovary syndrome	0.000295	0.0135	CcSEcCtD
Etonogestrel—Constipation—Metformin—polycystic ovary syndrome	0.000293	0.0134	CcSEcCtD
Etonogestrel—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000282	0.0129	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00028	0.0128	CcSEcCtD
Etonogestrel—Levonorgestrel—SHBG—polycystic ovary syndrome	0.000276	0.0339	CrCbGaD
Etonogestrel—Urticaria—Metformin—polycystic ovary syndrome	0.000272	0.0124	CcSEcCtD
Etonogestrel—Abdominal pain—Metformin—polycystic ovary syndrome	0.00027	0.0124	CcSEcCtD
Etonogestrel—Danazol—PGR—polycystic ovary syndrome	0.000269	0.0331	CrCbGaD
Etonogestrel—Danazol—SHBG—polycystic ovary syndrome	0.000251	0.0309	CrCbGaD
Etonogestrel—Asthenia—Metformin—polycystic ovary syndrome	0.000245	0.0112	CcSEcCtD
Etonogestrel—Pruritus—Metformin—polycystic ovary syndrome	0.000242	0.0111	CcSEcCtD
Etonogestrel—Levonorgestrel—AR—polycystic ovary syndrome	0.000242	0.0297	CrCbGaD
Etonogestrel—Norethindrone—PGR—polycystic ovary syndrome	0.000239	0.0294	CrCbGaD
Etonogestrel—Diarrhoea—Metformin—polycystic ovary syndrome	0.000234	0.0107	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—SHBG—polycystic ovary syndrome	0.000233	0.0286	CrCbGaD
Etonogestrel—Dizziness—Metformin—polycystic ovary syndrome	0.000226	0.0103	CcSEcCtD
Etonogestrel—Norethindrone—SHBG—polycystic ovary syndrome	0.000224	0.0275	CrCbGaD
Etonogestrel—Danazol—AR—polycystic ovary syndrome	0.00022	0.0271	CrCbGaD
Etonogestrel—Vomiting—Metformin—polycystic ovary syndrome	0.000218	0.00994	CcSEcCtD
Etonogestrel—Rash—Metformin—polycystic ovary syndrome	0.000216	0.00986	CcSEcCtD
Etonogestrel—Dermatitis—Metformin—polycystic ovary syndrome	0.000216	0.00985	CcSEcCtD
Etonogestrel—Headache—Metformin—polycystic ovary syndrome	0.000214	0.0098	CcSEcCtD
Etonogestrel—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000212	0.0261	CrCbGaD
Etonogestrel—Nausea—Metformin—polycystic ovary syndrome	0.000203	0.00929	CcSEcCtD
Etonogestrel—Levonorgestrel—CYP19A1—polycystic ovary syndrome	0.000203	0.0249	CrCbGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000195	0.00321	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—NR3C1—polycystic ovary syndrome	0.000189	0.00312	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000189	0.00312	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—BAX—polycystic ovary syndrome	0.000189	0.00311	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000187	0.00309	CbGpPWpGaD
Etonogestrel—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000187	0.00309	CbGpPWpGaD
Etonogestrel—Methyltestosterone—AR—polycystic ovary syndrome	0.000186	0.0229	CrCbGaD
Etonogestrel—ESR1—Signaling by ERBB4—YAP1—polycystic ovary syndrome	0.000185	0.00306	CbGpPWpGaD
Etonogestrel—Danazol—CYP19A1—polycystic ovary syndrome	0.000185	0.0227	CrCbGaD
Etonogestrel—PGR—Signaling by ERBB4—NRG1—polycystic ovary syndrome	0.000184	0.00304	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—GAB1—polycystic ovary syndrome	0.000183	0.00302	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000182	0.003	CbGpPWpGaD
Etonogestrel—Testosterone—CYP11A1—polycystic ovary syndrome	0.000175	0.0215	CrCbGaD
Etonogestrel—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000172	0.00284	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.000168	0.00278	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—LSM5—polycystic ovary syndrome	0.000167	0.00275	CbGpPWpGaD
Etonogestrel—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000166	0.00273	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—INS—polycystic ovary syndrome	0.000165	0.00272	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—TNRC6B—polycystic ovary syndrome	0.000164	0.0027	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PGR—polycystic ovary syndrome	0.000162	0.00267	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000161	0.00265	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—LEP—polycystic ovary syndrome	0.000159	0.00263	CbGpPWpGaD
Etonogestrel—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000159	0.00263	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IRS2—polycystic ovary syndrome	0.000158	0.0026	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000156	0.00258	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000156	0.00258	CbGpPWpGaD
Etonogestrel—Methyltestosterone—CYP19A1—polycystic ovary syndrome	0.000156	0.0192	CrCbGaD
Etonogestrel—PGR—Gene Expression—SAP30L—polycystic ovary syndrome	0.000155	0.00256	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000144	0.00238	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—IRS1—polycystic ovary syndrome	0.000142	0.00234	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000141	0.00233	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000141	0.00233	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—BCL2—polycystic ovary syndrome	0.000139	0.0023	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IRS1—polycystic ovary syndrome	0.000138	0.00227	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000135	0.00222	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000133	0.0022	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—TEAD2—polycystic ovary syndrome	0.000132	0.00217	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PRL—polycystic ovary syndrome	0.000131	0.00217	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000131	0.00216	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.00013	0.00215	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—AKT2—polycystic ovary syndrome	0.000127	0.0021	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000127	0.0021	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000127	0.00209	CbGpPWpGaD
Etonogestrel—Testosterone—SHBG—polycystic ovary syndrome	0.000123	0.0151	CrCbGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000121	0.00199	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ADARB1—polycystic ovary syndrome	0.00012	0.00198	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000119	0.00196	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000118	0.00194	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000113	0.00186	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000112	0.00185	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000111	0.00183	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.00011	0.00182	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00011	0.00181	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000108	0.00179	CbGpPWpGaD
Etonogestrel—Testosterone—AR—polycystic ovary syndrome	0.000108	0.0133	CrCbGaD
Etonogestrel—ESR1—Signaling by ERBB4—NRG1—polycystic ovary syndrome	0.000108	0.00178	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000108	0.00178	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000105	0.00173	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	9.78e-05	0.00161	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—LSM5—polycystic ovary syndrome	9.78e-05	0.00161	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NPB—polycystic ovary syndrome	9.47e-05	0.00156	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RPL37A—polycystic ovary syndrome	9.38e-05	0.00155	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IRS2—polycystic ovary syndrome	9.25e-05	0.00153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	9.17e-05	0.00151	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	9.17e-05	0.00151	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	9.09e-05	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SAP30L—polycystic ovary syndrome	9.09e-05	0.0015	CbGpPWpGaD
Etonogestrel—Testosterone—CYP19A1—polycystic ovary syndrome	9.04e-05	0.0111	CrCbGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	8.93e-05	0.00147	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—AR—polycystic ovary syndrome	8.88e-05	0.00146	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	8.87e-05	0.00146	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	8.85e-05	0.00146	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	8.76e-05	0.00144	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.56e-05	0.00141	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	8.52e-05	0.00141	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	8.12e-05	0.00134	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IRS1—polycystic ovary syndrome	8.08e-05	0.00133	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.9e-05	0.0013	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.9e-05	0.0013	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	7.76e-05	0.00128	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—TEAD2—polycystic ovary syndrome	7.73e-05	0.00128	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	7.67e-05	0.00127	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT2—polycystic ovary syndrome	7.48e-05	0.00123	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.39e-05	0.00122	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	7.21e-05	0.00119	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	7.19e-05	0.00119	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	7.18e-05	0.00118	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.17e-05	0.00118	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	7.15e-05	0.00118	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	7.06e-05	0.00116	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.98e-05	0.00115	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INHBB—polycystic ovary syndrome	6.8e-05	0.00112	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	6.7e-05	0.00111	CbGpPWpGaD
Etonogestrel—Testosterone—CYP1A1—polycystic ovary syndrome	6.65e-05	0.00818	CrCbGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	6.56e-05	0.00108	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FLT4—polycystic ovary syndrome	6.36e-05	0.00105	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.35e-05	0.00105	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—YAP1—polycystic ovary syndrome	6.29e-05	0.00104	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	6.28e-05	0.00104	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	6.28e-05	0.00104	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	6.23e-05	0.00103	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	5.86e-05	0.000967	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	5.8e-05	0.000957	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	5.78e-05	0.000954	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FSHR—polycystic ovary syndrome	5.78e-05	0.000954	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IL6—polycystic ovary syndrome	5.76e-05	0.00095	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	5.56e-05	0.000917	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	5.56e-05	0.000917	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	5.55e-05	0.000916	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	5.51e-05	0.000909	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	5.44e-05	0.000898	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.44e-05	0.000897	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	5.33e-05	0.00088	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.29e-05	0.000873	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	5.21e-05	0.00086	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	5.19e-05	0.000857	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FST—polycystic ovary syndrome	5.15e-05	0.00085	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	5.12e-05	0.000845	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.09e-05	0.00084	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	5.03e-05	0.00083	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	5.02e-05	0.000829	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	5.01e-05	0.000826	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.92e-05	0.000811	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	4.91e-05	0.000811	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	4.84e-05	0.000798	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	4.83e-05	0.000797	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	4.76e-05	0.000786	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.76e-05	0.000786	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	4.71e-05	0.000778	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.64e-05	0.000765	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.64e-05	0.000765	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	4.55e-05	0.000751	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.5e-05	0.000742	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	4.42e-05	0.000729	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	4.38e-05	0.000723	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	4.34e-05	0.000716	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	4.32e-05	0.000713	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AR—polycystic ovary syndrome	4.27e-05	0.000705	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	4.21e-05	0.000695	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	4.21e-05	0.000695	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.1e-05	0.000676	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	4.09e-05	0.000675	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	4.07e-05	0.000672	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	4.04e-05	0.000666	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	3.99e-05	0.000659	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	3.86e-05	0.000637	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	3.82e-05	0.000631	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	3.77e-05	0.000622	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	3.74e-05	0.000616	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.73e-05	0.000615	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	3.69e-05	0.000609	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.67e-05	0.000605	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.61e-05	0.000595	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	3.46e-05	0.00057	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	3.39e-05	0.00056	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	3.38e-05	0.000558	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	3.32e-05	0.000548	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	3.32e-05	0.000548	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.26e-05	0.000538	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	3.26e-05	0.000538	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PGR—polycystic ovary syndrome	3.23e-05	0.000532	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.19e-05	0.000527	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	3.17e-05	0.000523	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.1e-05	0.000512	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.09e-05	0.00051	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.08e-05	0.000508	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.04e-05	0.000501	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	3.03e-05	0.000499	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.99e-05	0.000493	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	2.95e-05	0.000487	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.94e-05	0.000485	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	2.92e-05	0.000482	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	2.9e-05	0.000478	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.89e-05	0.000476	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.8e-05	0.000461	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	2.77e-05	0.000457	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.75e-05	0.000454	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.71e-05	0.000447	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—polycystic ovary syndrome	2.68e-05	0.000442	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.64e-05	0.000436	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.59e-05	0.000428	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.57e-05	0.000424	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	2.55e-05	0.000421	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AR—polycystic ovary syndrome	2.51e-05	0.000414	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.48e-05	0.000409	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.48e-05	0.000409	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.43e-05	0.000401	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	2.41e-05	0.000398	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.4e-05	0.000396	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	2.38e-05	0.000393	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.37e-05	0.000391	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.3e-05	0.00038	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.3e-05	0.000379	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	2.26e-05	0.000374	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	2.19e-05	0.000362	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.15e-05	0.000355	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.12e-05	0.000349	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	2.1e-05	0.000346	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	2.04e-05	0.000337	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	2.03e-05	0.000335	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	2e-05	0.00033	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.96e-05	0.000323	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.96e-05	0.000323	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.95e-05	0.000322	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.95e-05	0.000322	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.86e-05	0.000307	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.81e-05	0.000299	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	1.78e-05	0.000294	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	1.72e-05	0.000283	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.72e-05	0.000283	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INS—polycystic ovary syndrome	1.71e-05	0.000282	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	1.7e-05	0.000281	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	1.65e-05	0.000272	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	1.65e-05	0.000272	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.64e-05	0.000271	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.61e-05	0.000266	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	1.57e-05	0.000259	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.57e-05	0.000259	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.56e-05	0.000257	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.5e-05	0.000247	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.48e-05	0.000245	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.43e-05	0.000235	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.42e-05	0.000234	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.4e-05	0.000231	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.32e-05	0.000218	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.26e-05	0.000208	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.2e-05	0.000198	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	1.17e-05	0.000193	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.15e-05	0.00019	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.13e-05	0.000186	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.09e-05	0.00018	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.08e-05	0.000178	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.05e-05	0.000173	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	1.01e-05	0.000166	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1e-05	0.000165	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	1e-05	0.000165	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.71e-06	0.00016	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.69e-06	0.00016	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.68e-06	0.00016	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	9.36e-06	0.000154	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.2e-06	0.000152	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	8.99e-06	0.000148	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.88e-06	0.000147	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	8.39e-06	0.000138	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	8.26e-06	0.000136	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	7.46e-06	0.000123	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.15e-06	0.000118	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.95e-06	0.000115	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.54e-06	0.000108	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.33e-06	0.000104	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.83e-06	9.62e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.56e-06	9.17e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.27e-06	8.69e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.91e-06	8.1e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	4.38e-06	7.22e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.98e-06	6.57e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.93e-06	6.48e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.91e-06	6.44e-05	CbGpPWpGaD
